Trials / Unknown
UnknownNCT03931668
Tolerance, PK and PD Effects Study of TPN-672 in Chinese Healthy Volunteers
A Single Site, Randomized, Double-blind, Placebo-controlled, Incremental Phase I Clinical Trial: to Evaluate the Tolerance, PK and PD Effects of TPN-672 Maleate in Chinese Healthy Volunteers After Single Dose Administration.
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a single-site, randomized, double-blind, placebo-controlled, incremental phase I clinical trial to evaluate preliminarily the tolerance, pharmacokinetics and pharmacodynamic effects of TPN672 maleate in Chinese healthy volunteers after single dose administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TPN-672 | single dose of TPN-672 maleate tablet |
Timeline
- Start date
- 2019-04-17
- Primary completion
- 2020-10-17
- Completion
- 2020-12-17
- First posted
- 2019-04-30
- Last updated
- 2019-12-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03931668. Inclusion in this directory is not an endorsement.